Allogeneic peripheral blood stem cell transplantation for the treatment of refractory follicular lymphoma

Internal Medicine

Volumn 37, Issue 12, 1998, Pages 1050-1054

  Masuda, Ritsuko ^a,b   Teshima, Takanori ^a   Ishimaru, Fumihiko ^a   Shinagawa, Katsuji ^a   Nakayama, Hiroyuki ^a   Shimono, Michihide ^a   Asakura, Shoji ^a   Ohmoto, Eijiro ^a   Harada, Mine ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b Fuchu General Hospital   (Japan)

Author keywords

Allotransplantation; High dose chemotherapy; Peripheral blood stem cell (PBSC)

Indexed keywords

ANTINEOPLASTIC AGENT; ASPARAGINASE; CARBOPLATIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTOMEGALOVIRUS ANTIBODY; DAUNORUBICIN; DOXORUBICIN; ETOPOSIDE; GANCICLOVIR; IFOSFAMIDE; METHOTREXATE; METHYLPREDNISOLONE; PREDNISOLONE; PREDNISONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; VINCRISTINE; VINCRISTINE SULFATE; VINDESINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ADVANCED CANCER; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER REGRESSION; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC TEST; DOSE RESPONSE; DRUG EFFICACY; FOLLICULAR LYMPHOMA; GENE REARRANGEMENT; GRAFT VERSUS HOST REACTION; HUMAN; IATROGENIC DISEASE; INTERMETHOD COMPARISON; MALE; METASTASIS; MULTIMODALITY CANCER THERAPY; ORAL DRUG ADMINISTRATION; PERIPHERAL BLOOD STEM CELL; SPLENOMEGALY; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

EID: 0032454359     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.37.1050     Document Type: Article

References (26)

1. Harada M. Allogeneic peripheral blood stem cell transplantation is coming of age. Int J Hematol 62: 1-5, 1995.
2. Bensinger WI, Gift RA, Anasetti C, et al. Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony stimulating factor. Stem Cells 14: 90-105, 1996.
3. Russel N, Gratwohl A, Schmitz N. The place of blood stem cells in allogeneic transplantation. Br J Haematol 93: 747-753, 1996.
4. Korbling M, Przepiorka D, Huh YO, et al. Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: Potential advantage of blood over marrow allograft. Blood 85: 1659-1665, 1995.
5. Schmitz N, Dreger P, Suttorp M, et al. Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (Granulocyte colony stimulating factor). Blood 85: 1666-1672, 1995.
6. Rosenfeld C, Collins R, Pineiro L, et al. Allogeneic blood cell transplantation without posttransplant colony stimulating factors in patients with hematopoietic neoplasm: a phase II study. J Clin Oncol 14: 1314-1319, 1996.
7. Bacigalupo A, Van Lint MT, Valbonesi M, et al. Thiotepa, Cyclophosphamide followed by granulocyte colony stimulating factor mobilized allogeneic peripheral blood cells in adults with advanced leukemia. Blood 88: 353-357, 1996.
8. Gribben JG, Freedman AS, Woo SD, et al. All advanced stage non-Hodgkin's lymphomas with a polymerase chain reaction amplifiable breakpoint of bcl-2 have residual cells containing the bcl-2rearrangement at evaluation and after treatment. Blood 78: 3275-3280, 1991.
9. Larson RA, Dodge RK, Burns CP, et al. A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: Cancer and Leukemia Group B Study 8811. Blood 85: 2025-2037, 1995.
10. Matsuishi E, Saito S, Miyamoto Y, et al. Allogeneic peripheral blood stem cell transplantation for treatment of induction failure in a patient with Philadelphia chromosome-positive acute lymphoblastic leukemia. Int J Hematol 61: 43-47, 1995.
11. Harada M, Nagafuji K, Fujisaki T. et al. G-CSF-induced mobilization of peripheral blood stem cell from healthy adults for allogeneic transplantation. J Hematotherapy 5: 63-71, 1996.
12. Katayama Y, Yano Y, Bessho A, et al. The effects of a simplified method for cryopreservation and thawing procedures on peripheral blood stem cells. Bone Marrow Transplant 19: 283-287, 1997.
13. Gondo H, Minematsu T, Harada M, et al. Cytomegalovirus (CMV) antigenaemia for rapid diagnosis and monitoring of CMV-associated disease after bone marrow transplantation. Br J Haematol 86: 130-137, 1994.
14. Przepiorka D, Weisdorf D, Martin P, et al. Consensus conference on acute GVHD grading. Bone Marrow Transplant 15: 825-828, 1995.
15. Siada KM, Sullivan KM. The management of chronic graft-versus-host disease. Blood Reviews 8: 154-160, 1994.
16. Coiffier B. How should prognostic factors influence therapy in follicular lymphomas? Ann Oncol 2: 619-620, 1991.
17. Besa PC, McLaughlin PW, Cox JD, et al. Long term assessment of patterns of treatment failure and survival in patients with stage I or II follicular lymphoma. Cancer 75: 2361-2367, 1995.
18. Horning SJ, Rosenberg SA. The natural history of initially untreated low-grade non-Hodgkin's lymphomas. N Engl J Med 311: 1471-1475, 1984.
19. Freedman AS, Ritz J, Neuberg D, et al. Autologous bone marrow transplantation in 69 patients with a history of low-grade B-cell non-Hodgkin's lymphomas. Blood 77: 2524-2529, 1991.
20. Armitage JO. Bone marrow transplantation. N Engl J Med 330:827-838, 1994.
21. Press OW, Fisher R, Dala-Favera R. Aggressive non-Hodgkin's lymphomas. In: Hematology 1996 Education Program, American Society of Hematology, 1996:48.
22. Lister TA. High dose therapy and stem cell transplantation. In. Presidential Symposium "Have we changed the natural history of follicular lymphoma?" (Moderator: Armitage JO), 33rd Annual Meeting of American Society of Clinical Oncology, May 17-20, 1997, Denver, Colorado.
23. Jones RJ, Ambinder RF, Piantadosi S. et al. Evidence of a graft-versus-lymphoma effect associated with allogeneic bone marrow transplantation. Blood 77: 649-653, 1991.
24. Ratanatharathorn V, Uberti J, Karanes C, et al. Prospective comparative trial of autologous versus allogeneic bone marrow transplantation in patients with non-Hodgkin's lymphoma. Blood 84: 1050-1055, 1994.
25. van Besien KW, Khouri IF, Giralt SA, et al. Allogeneic bone marrow transplantation for refractory and recurrent low-grade lymphoma: The case for aggressive management. J Clin Oncol 13: 1096-1102, 1995.
26. Ottinger HD, Beelen DW, Scheulen B, et al. Improved immune reconstitution after allotransplantation of peripheral blood stem cells instead of bone marrow. Blood 88: 2775-2779, 1996.